Skip to main content
Caplight Logo









ReumaNederland

ReumaNederland

Overview

ReumaNederland is a Dutch non-profit patient organization and research funder that invests in and finances initiatives and scientific research for the treatment of rheumatism.

Year Founded

1926

Portfolio Companies

2

Investments

ReumaNederland investments
CompanyDateStageLead
Hy2CareApr 2019Series ACo-investor
ManometricOct 2018SeedCo-investor

Key People

Petra Borsje-van den Berg

Patient Research Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is ReumaNederland based?

ReumaNederland is headquartered in Amsterdam, Netherlands.

When was ReumaNederland founded?

ReumaNederland was founded in 1926.

How many portfolio companies does ReumaNederland have?

ReumaNederland has 2 portfolio companies in Caplight's dataset.

What are some companies in ReumaNederland's portfolio?

Portfolio companies visible on Caplight include Hy2Care, Manometric.

What was ReumaNederland's most recent investment shown here?

ReumaNederland's most recent investment in this portfolio sample was in Hy2Care in 2019.

What sectors does ReumaNederland focus on?

ReumaNederland focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.

What company stages does ReumaNederland focus on?

ReumaNederland typically invests at the Early stage.

Firmographic Details

HeadquartersAmsterdam
Year Founded1926

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?